A 10 day intraventricular administration of 0.025 μg μL−1 jujubosides improved learning and memory in Alzheimer’s disease (AD) model mice by mitigating sevoflurane-induced mitochondrial-related apoptotic signaling, reducing β-amyloid aggregation, decreasing Tau protein phosphorylation, and inhibiting hippocampal neuronal apoptosis [48]. This evidence concerns the gene MAPT and Alzheimer disease.